The fourth element targeting hypothesis of Alzheimer's disease pathogenesis and pathophysiology

Frontiers in Neurology

Volumn NOV, Issue , 2010, Pages

  Kuljiš, Rodrigo O ^a  

^a Encephalogistics Inc   (United States)

Author keywords

astrocyte; Alzheimer's disease; Beta astrocyte; Dementia; Microglia; Neurodegeneration; Neuroglia; Polydendrocyte

Indexed keywords

EID: 84861802731     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2010.00144     Document Type: Article

References (56)

1. Ager, R. R., Fonseca, M. I., Chu, S. H., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., and Tenner, A. J. (2010). Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. J. Neurochem. 113, 389-401.
2. Alzheimer, A. (1906). "Über eine eigenartige Erkrankung der Hinrinde," in Allgemenine Zeitschrift für Psychiatrie und Psychisch-Gerichtliche Medizin, Vol. LXIV, eds E. Schultze and O. Snell (Berlin: Reimer, G), 146-148.
3. Alzheimer, A. (1907). "A singular disorder that affects the cerebral cortex," Neurologic Classics in Modern Translation, eds C. N. Hochberg and F. H. Hochberg (New York: Hafner Press), 41-43.
4. Arendt, T. (2009). Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167-179.
5. Bayer, T. A., and Wirths, O. (2010). Intracellular accumulation of amyloid-beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front. Aging Neurosci. 2:8. doi: 10.3389/fnagi.2010.00008.
6. Beach, T. G., Walker, R., and McGeer, E. G. (1989). Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2, 420-436.
7. Bell, K. F., and Cuello, C. (2006). Altered synaptic function in Alzheimer's diseases. Eur. J. Pharmacol. 545, 11-21.
8. Bergles, D. E., Jabs, R., and Steinhäuser, C. (2010). Neuron-glia synapses in the brain. Brain Res. Rev. 63, 130-137.
9. Bergles, D. E., Roberrts, J. D. B., Somogyi, P., and Jahr, C. E. (2000). Glutamatergic synapses on oligodendrocyte precursor cells in hippocampus. Nature 405, 187-191.
10. Bianchi, R., Giambanco, I., and Donato, R. (2010). S100B/RAGE-dependent activation of microglia via NF-κB and AP-1 co-regulation of COX-2 expression by S100B, IL-1ß and TNF-a. Neurobiol. Aging 31, 665-677.
11. Crols, R., Saerens, J., Noppe, M., and Lowenthal, A. (1986). Increased GFAP levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome. J. Neurol. 233, 157-160.
12. De Kosky, S. T., and Scheff, S. W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464.
13. De Meyer, G., Shapiro, F., Vanderstichele, H., Vanmechelen, E., Engelborghs, S., De Deyn, P. P., Coart, E., Hansson, O., Minthon, L., Zetterberg, H., Blennow, K., Shawm, L., and Trojanowski, J. Q. (2010). Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67, 949-956.
14. Eikelenboom, P., van Exel, E., Hoozemans, J. J., Veerhuis, R., Rozemuller, A. J., and van Gool, W. A. (2010). Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease. Neurodeg. Dis. 7, 38-41.
15. Fernández, J., Rojo, L., Kuljiš, R. O., and Maccioni, R. B. (2008). The damage signals hypothesis of Alzheimer's disease. J. Alzheimers Dis. 14, 329-333.
16. Fukuyama, R., Izumoto, T., and Fushiki, S. (2001). The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia. Eur. Neurol. 46, 35-38.
17. Gleckman, A. M., Jiang, Z., Liu, Y., and Smith, T. W. (1999). Neuronal and glial DNA fragmentation in Pick's disease. Acta Neuropathol. (Berl.) 98, 55-61.
18. Heneka, M. T., O'Banion, M. K., Terwel, D., and Kummer, M. P. (2010). Neuroinflammatory processes in Alzheimer's disease. J. Neural. Transm. 117, 919-947.
19. Johnstone, M., Gearing, A. J. H., and Miller, K. M. (1999). A central role for astrocytes in the inflammatory response to ß-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93, 182-193.
20. Kashon, M. L., Ross, G. W., O'Callaghan, J. P., Miller, D. B., Petrovich, H., Burchfield, C. M., Sharp, D. S., Markesberry, W. R., Davis, D. G., Hardman, J., Nelson, J., and White, L. R. (2004). Association of cortical astrogliosis with cognitive performance and dementia status. J. Alzheimers Dis. 6, 595-604.
21. Kuljiš, R. O. (2009a). Toward a multi-dimensional formulation of the pathogenesis and pathophysiology of the Alzheimer dementia-like syndrome applicable to a variety of degenerative disorders and normal cognition. Med. Hypotheses 73, 315-318.
22. Kuljiš, R. O. (2009b). "Selective cerebrocortical regional, laminar, modular and cellular vulnerability and sparing in Alzheimer's disease: unexploited clues to pathogenesis, pathophysiology, molecular- and systems-level hypothesis generation and testing," in Current Hypotheses and Research Milestones in Alzheimer's Disease, eds R. B. Maccioni and G. Perry (New York/Heidelberg: Springer Science and Business Media), 191-204.
23. Kuljiš, R. O. (2010a). Grand Challenges in Dementia 2010. Front. Neur. 1:4. doi: 10.3389/fneur.2010.00004.
24. Kuljiš, R. O. (2010b). Integrative understanding of emergent brain properties, quantum brain hypotheses and connectome alterations in dementia are key challenges to conquer Alzheimer's disease. Front. Neur. 1:15. doi: 10.3389/fneur.2010.00015.
25. Kuljiš, R. O., and Šalković-Petrišić, M. (2010). Dementia, diabetes, Alzheimer's disease and insulin resistance in the brain: progress, dilemmas and new opportunities to tackle intersecting epidemics. J. Alzheimers Dis. (in press).
26. Leung, E., Guo, L., Bu, J., Maloof, M., El Khoury, J., and Geula, C. (2009). Microglia activation mediates fibrillar amyloid-ß toxicity in the aged primate cortex. Neurobiol. Aging. doi: 10.1016/j.neurobiolaging.2009.02.025.
27. Marshak, D. R., Pesce, S. A., Stanley, L. C., and Griffin, W. S. (1992). Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging 13, 1-7.
28. Miklossy, J., Qing, H., Radenovic, A., Kis A., Vileno, B., Làszló, F., Miller, L., Martins, R. N., Waeber, G., Mooser, V., Bosmang, F., Khalili, K., Darbinian, N., and McGeer, P. L. (2010). Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol. Aging 31, 1503-1515.
29. Morgan, T. E., Rozovsky, I., Goldsmith, S. K., Stone, D. J., Yoshida, T., and Finch, C. E. (1997). Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic. Biol. Med. 23, 524-528.
30. Myung, N. H., Zhu, X., Kruman, I. I., Castellani, R. J., Petersen, R. B., Siediak, S. L., Perry, G., Smith, M. A., and Lee, H. G. (2008). Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. AGE 30, 209-215.
31. Naegele, R.G., D'Andrea, M. R., Lee, H., Venkataraman, V., and Wang, H. Y. (2003). Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 971, 197-209.
32. Nishiyama, A., Komitova, M., Suzuki, R., and Zhu, X. (2009). Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 10, 9-22.
33. Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., and Smith, M. A. (2006a). Involvement of oxidative stress in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 65, 631-641.
34. Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Perry, G., and Smith, M. A. (2006b). Oxidative damage to RNA in neurodegenerative diseases. J. Neuropathol. Biomed. Biothechnol. 2006, 82323.
35. Peress, N. S., Fleit, H. B., Perillo, E., Kuljiš, R. O., and Pezullo, C. (1993). Identification of FcγRI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J. Neuroimmunol. 48, 71-80.
36. Pertusa, M., García-Matas, S., Rodríguez-Farre, E., Sanfeliu, C., and Cristofol, R. (2007). Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem. 101, 794-805.
37. Perusini, G. (1910). "Über klinisch un histologisch eigenartige psychische Erkrankungen des spätern Lebensalters, "in Histologische und histopathologische Arbeiten, Vol. III, eds F. Nissl and A. Alzheimer (Jena: Fischer, G), 297-351.
38. Perusini, G. (1911). Sul valore nosografico di alcuni reperti istopatologici carattersitici per la senilitá. Riv. Ital. Neuropatol. Psiquiatr. Elettroter. IV, 193-213.
39. Peskind, E. R., Griffin, W. S., Akama, K. T., Raskind, M. A., and Van Eldik, L. J. (2001). Cerebrospinal fluid S110B is elevated in the earlier stages of Alzheimer's disease. Neurochem. Int. 39, 409-413.
40. Peters, A. (2004). A fourth type of neuroglial cell in the adult central nervous system. J. Neurocytol. 33, 345-257.
41. Petzold, A., Jenkins, R., Watt, H. C., Green, A. J., Thompson, E. J., Keir, G., Fox, N. C., and Rossor, M. N. (2003). Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neurosci. Lett. 336, 167-170.
42. Reyners, H., de Reyners, E. G., and Maisin, J-R. (1982). The "beta astrocyte" a newly recognized radiosensitive glial cell type in the cerebral cortex. J. Neurocytol. 11, 967-983.
43. Reyners, H., de Reyners, E. G., Regniers, L., and Maisin, J.-R. (1986). A glial progenitor cell in the cerebral cortex of the adult rat. J. Neurocytol. 15, 53-61.
44. Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., and Grover, A. (2007). Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int. Rev. Neurobiol. 82, 235-246.
45. Rojo, L. E., Fernández, J., Jiménez, J., Maccioni, A. A., Sekler, A., Kuljiš, R. O., and Maccioni, R. B. (2009). "Central nervous system inflammation and cholesterol metabolism alterations in the pathogenesis of Alzheimer's disease and diagnosis of Alzheimer's disease," in Current Hypotheses and Research Milestones in Alzheimer's Disease, eds R. B. Maccioni and G. Perry (New York/Heidelberg: Springer Science and Business Media), 125-138.
46. Sastre, M., Klockgether, T., and Heneka, M. T. (2006). Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24, 167-176.
47. Selinfreund, R. H., Barger, S. W., Pledger, W. J., and Van Eldik, L. J. (1991). Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88, 3554-3558.
48. Sheng, J. G., Mrak, R. E., and Griffin, W. S. (1994). S100 beta protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. Neurobiol. Aging 22, 915-922.
49. Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., and Wharton, S. B. (2010). Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 31, 578-590.
50. Steiner, J., Bernstein, H. G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Keilhoff, G., and Bogerts, B. (2007). Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 8, 2.
51. Streit, W. J., Braak, H., Xue, Q. S., and Bechmann, I. (2009). Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475-485.
52. Terry, R. D., Masliah, E., and Salmon, D. P. (1991). Physical basis of cognitive decline in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 41, 572-580.
53. Verwer, R. W. H., Sluiter, A. A., Balesar, R. A., Baayen, J. C., Noske, D. P., Dirven, C. M. F., Wouda, J., van Dam, A. M., Lucassen, P. J., and Swaab, D. F. (2007). Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. Brain 130, 3321-3335.
54. Wallin, A., Blennow, K., and Rosengren, L. E. (1996). Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia. Dementia 7, 267-272.
55. Wirths, O., Multhaup, G., and Bayer, T. A. (2004). A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide - the first step of a fatal cascade. J. Neurochem. 91, 513-520.
56. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., and Husemann, J. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457.